共 50 条
- [1] Tumor necrosis factor blockers in rheumatoid arthritis. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (11): : 810 - 811
- [3] Impact of Tumor Necrosis Factor Inhibition on Healthcare Costs in Patients with Rheumatoid Arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S171 - S171
- [4] Polymorphisms of tumor necrosis factor receptor I and II in patients with rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S194 - S194
- [5] Polymorphism at position-308 of the promoter of the tumor necrosis factor α gene and infliximab therapy in rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S394 - S394
- [6] Tumor necrosis factor-α-308 G/G promoter polymorphism correlates with a better response to adalimumab in patients with rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S561 - S562
- [8] Association of tumor necrosis factor α 5′-flanking region polymorphism with Japanese patients with rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S71 - S71
- [9] Weight gain associated with the administration of tumor necrosis factor alpha antagonists in patients with rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S170 - S170